Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Melatonin for Neuroprotection in Preterm Infants
NCT04235673Completed
- Start
- May 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in traumatic brain injury (TBI) comparing Melatonin with Placebo (2 arms). Primary endpoints: Malondialdehyde at 15 days and Melatonin at 15 days. Started May 2020; status: completed.
02
Drugs
melatonin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT04235673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04235673.